186 related articles for article (PubMed ID: 8615625)
1. Enhancement of antitumor effects of new analogue of platinum, cis-diammine (glycolato) platinum (254-S) combined with hyperthermia in vivo.
Jo A; Sakurai K; Tsumura M; Mizuuchi H; Yoshiga K; Takada K
Anticancer Res; 1996; 16(1):301-4. PubMed ID: 8615625
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
[TBL] [Abstract][Full Text] [Related]
3. Interaction of PtCl4(Fast Black)2 with hyperthermia.
Teicher BA; Herman TS; Pfeffer MR; Alvarez Sotomayor E; Khandekar VS
Cancer Res; 1989 Nov; 49(22):6208-13. PubMed ID: 2804969
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of carboplatin combined with radiation on tumors in mice.
Aratani Y; Yoshiga K; Mizuuchi H; Jo A; Tanimoto K; Sakurai K
Anticancer Res; 1997; 17(4A):2535-8. PubMed ID: 9252676
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
6. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo.
Takahashi I; Maehara Y; Kusumoto H; Kusumoto T; Baba H; Kohnoe S; Sugimachi K
Oncology; 1996; 53(1):68-72. PubMed ID: 8570136
[TBL] [Abstract][Full Text] [Related]
7. [Experimental pharmacologic and morphologic study of new platinum complexes].
Karanvanova M; Getov Kh; Topashka-Ancheva M; Bakalova A; Cholakova I
Eksp Med Morfol; 1989; 28(4):20-5. PubMed ID: 2627897
[TBL] [Abstract][Full Text] [Related]
8. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
9. Influence of 5-hydroxytryptamine on the combination effect of lonidamine or gossypol and hyperthermia on Ehrlich tumour in vivo.
Molla MR; Yoshiga K; Takada K
Anticancer Res; 1987; 7(3 Pt B):361-4. PubMed ID: 3631888
[TBL] [Abstract][Full Text] [Related]
10. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation.
Cemazar M; Pipan Z; Grabner S; Bukovec N; Sersa G
Anticancer Res; 2006; 26(3A):1997-2002. PubMed ID: 16827135
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of cis-diammine (glycolato) platinum (254-S), a new platinum antitumor agent, following an intravenous and intraperitoneal infusion bioactive platinum concentration profile].
Hirabayashi K; Okada E; Oguma T; Shimamura K
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2221-7. PubMed ID: 2241186
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
Endoh K; Akamatsu K; Matsumoto T; Morikawa K; Honda M; Mitsui H; Koizumi M; Koizumi K; Matsuno T
Anticancer Res; 1989; 9(4):987-91. PubMed ID: 2817826
[TBL] [Abstract][Full Text] [Related]
14. Enhanced inhibitory effects of hyperthermia combined with ascorbic acid on DNA synthesis in Ehrlich ascites tumor cells grown at a low cell density.
Kageyama K; Onoyama Y; Otani S; Matsui-Yuasa I; Nagao N; Miwa N
Cancer Biochem Biophys; 1995 Jan; 14(4):273-80. PubMed ID: 7767901
[TBL] [Abstract][Full Text] [Related]
15. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
[TBL] [Abstract][Full Text] [Related]
16. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Horsman MR
Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine(glycolato)platinum, 254-S.
Ota K; Oguma T; Shimamura K
Anticancer Res; 1994; 14(3B):1383-7. PubMed ID: 8067710
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity and nephrotoxicity of a novel platinum complex, [1,3-bis(diphenylphosphino)propane](trans-1-dach)platinum(I I) dinitrate.
Baek MS; Rho YS; Jung JC; Chang SG; Nomura M; Miyamoto KJ
Anticancer Res; 1997; 17(2A):955-9. PubMed ID: 9137434
[TBL] [Abstract][Full Text] [Related]
19. [Combination effects of CDDP and hyperthermia in mouse bladder tumor (MBT-2)].
Shimizu K
Hinyokika Kiyo; 1988 Apr; 34(4):627-32. PubMed ID: 3400547
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial and antitumor activity of platinum complexes of hydrazinopyrimidines and amidrazones.
Pelova R; Spassowska N; Maneva L; Taxirov S
Pharmazie; 1987 Apr; 42(4):251-2. PubMed ID: 3615558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]